title: National surveillance for influenza and influenza-like illness in Vietnam, 2006-2010.
abstract: Influenza virus infections result in considerable morbidity and mortality both in the temperate and tropical world. Influenza surveillance over multiple years is important to determine the impact and epidemiology of influenza and to develop a national vaccine policy, especially in countries developing influenza vaccine manufacturing capacity, such as Vietnam. We conducted surveillance of influenza and influenza-like illness in Vietnam through the National Influenza Surveillance System during 2006-2010. At 15 sentinel sites, the first two patients presenting each weekday with influenza-like illness (ILI), defined as fever and cough and/or sore throat with illness onset within 3 days, were enrolled and throat specimens were collected and tested for influenza virus type and influenza A subtype by RT-PCR. De-identified demographic and provider reported subsequent hospitalization information was collected on each patient. Each site also collected information on the total number of patients with influenza-like illness evaluated per week. Of 29,804 enrolled patients presenting with influenza-like illness, 6516 (22%) were influenza positive. Of enrolled patients, 2737 (9.3%) were reported as subsequently hospitalized; of the 2737, 527 (19%) were influenza positive. Across all age groups with ILI, school-aged children had the highest percent of influenza infection (29%) and the highest percent of subsequent hospitalizations associated with influenza infection (28%). Influenza viruses co-circulated throughout most years in Vietnam during 2006-2010 and often reached peak levels multiple times during a year, when >20% of tests were influenza positive. Influenza is an important cause of all influenza-like illness and provider reported subsequent hospitalization among outpatients in Vietnam, especially among school-aged children. These findings may have important implications for influenza vaccine policy in Vietnam.
authors.affiliation: National Institute of Hygiene and Epidemiology, Viet Nam.
authors.forename: Yen T
authors.initials: YT
authors.lastname: Nguyen
authors.forename: Samuel B
authors.initials: SB
authors.lastname: Graitcer
authors.forename: Tuan H
authors.initials: TH
authors.lastname: Nguyen
authors.forename: Duong N
authors.initials: DN
authors.lastname: Tran
authors.forename: Tho D
authors.initials: TD
authors.lastname: Pham
authors.forename: Mai T Q
authors.initials: MT
authors.lastname: Le
authors.forename: Huu N
authors.initials: HN
authors.lastname: Tran
authors.forename: Chien T
authors.initials: CT
authors.lastname: Bui
authors.forename: Dat T
authors.initials: DT
authors.lastname: Dang
authors.forename: Long T
authors.initials: LT
authors.lastname: Nguyen
authors.forename: Timothy M
authors.initials: TM
authors.lastname: Uyeki
authors.forename: David
authors.initials: D
authors.lastname: Dennis
authors.forename: James C
authors.initials: JC
authors.lastname: Kile
authors.forename: Bryan K
authors.initials: BK
authors.lastname: Kapella
authors.forename: A D
authors.initials: AD
authors.lastname: Iuliano
authors.forename: Marc-Alain
authors.initials: MA
authors.lastname: Widdowson
authors.forename: Hien T
authors.initials: HT
authors.lastname: Nguyen
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D062665:Epidemiological Monitoring; D005260:Female; D006760:Hospitalization; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D009980:Influenza A virus / Q000302:isolation & purification*; D007252:Influenza Vaccines / Q000627:therapeutic use; D007251:Influenza, Human / Q000453:epidemiology*; D008297:Male; D008875:Middle Aged; D014744:Vietnam / Q000453:epidemiology; D055815:Young Adult
chemical_list: D007252:Influenza Vaccines
keywords: ILI; Influenza; Influenza A (H1N1) subtype; Influenza A (H3N2) subtype; Influenza B; NISS; National Influenza Surveillance System; Pandemic influenza; RT-PCR; Southeast Asia; Vietnam; influenza-like illness; reverse transcription-polymerase chain reaction
references.citation: N Engl J Med. 2010 Jun 10;362(23):2175-2184
references.pmid: 20558368
references.citation: Vaccine. 2009 Dec 11;28(2):398-402
references.pmid: 19853073
references.citation: Nature. 2008 May 29;453(7195):615-9
references.pmid: 18418375
references.citation: BMC Public Health. 2011 Apr 14;11:234
references.pmid: 21492445
references.citation: Public Health. 2011 Jun;125(6):389-95
references.pmid: 21616513
references.citation: PLoS Med. 2006 Apr;3(4):e89
references.pmid: 16509764
references.citation: JAMA. 2003 Jan 8;289(2):179-86
references.pmid: 12517228
references.citation: Influenza Other Respir Viruses. 2010 Mar;4(2):47-52
references.pmid: 20167044
references.citation: Aust N Z J Public Health. 2001 Oct;25(5):443-6
references.pmid: 11688625
references.citation: Vaccine. 2004 Nov 25;23(2):182-7
references.pmid: 15531035
references.citation: Vaccine. 2008 Sep 12;26 Suppl 4:D31-4
references.pmid: 19230156
references.citation: Jpn J Infect Dis. 2008 Jul;61(4):321-3
references.pmid: 18653981
references.citation: Ann Intern Med. 2009 Dec 15;151(12):829-39
references.pmid: 20008759
references.citation: MMWR Recomm Rep. 2010 Aug 6;59(RR-8):1-62
references.pmid: 20689501
references.citation: Curr Opin Infect Dis. 2010 Oct;23(5):415-20
references.pmid: 20644472
references.citation: Influenza Other Respir Viruses. 2008 May;2(3):81-92
references.pmid: 19453467
references.citation: Clin Infect Dis. 2010 Mar 1;50(5):747-51
references.pmid: 20121411
references.citation: PLoS One. 2009 Nov 11;4(11):e7776
references.pmid: 19936224
references.citation: Pharm World Sci. 2008 Jan;30(1):39-43
references.pmid: 17602309
references.citation: J Med Econ. 2008;11(4):639-50
references.pmid: 19450073
references.citation: PLoS Med. 2010 May 18;7(5):e1000277
references.pmid: 20502525
references.citation: Vaccine. 2006 May 15;24(20):4417-26
references.pmid: 16621187
references.citation: Clin Infect Dis. 2004 Aug 15;39(4):443-9
references.pmid: 15356802